Jimmy Kimmel has been roasting Donald Trump’s cabinet picks on Live, but with Matt Gaetz withdrawing from consideration for Attorney General, it looks like Kimmel has set his sights on Trump’s controversial pick to lead the Department of Health and Human Services: Robert F. Kennedy Jr.
Collegium Pharmaceutical’s pain management portfolio, including Xtampza ER and Belbuca, drives 92.8% of revenues. Read why I’m very bullish on COLL stock.
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (SG:T14) has released an update. Tianjin Pharmaceutical Da Ren Tang Group Corp. has
The costly proposal from the U.S. Department of Health and Human Services sets the stage for a potential showdown between the powerful pharmaceutical industry and Robert F. Kennedy Jr., an outspoken opponent of the weight-loss drugs who, as President-elect …
CSPC Pharmaceutical Group (HK:1093) has released an update. CSPC Pharmaceutical Group has announced that its subsidiary’s biologic license
Investors looking for a way to pump up their passive income streams want to turn their attention toward the pharmaceutical industry. Shares of Pfizer (NYSE: PFE) and AbbVie (NYSE: ABBV) have underperformed over the past couple of years,
PCI Pharma Services is a winner in the Innovation and Business Expansion categories in the 2024 Pharmaceutical Technology Excellence Awards.
TOPEKA, Kan. (WIBW) – Several states have reached a settlement with two pharmaceutical companies accused of jacking up prices in the generic drug market. The Kansas Attorney General’s Office says anyone who purchased a generic drug manufactured by …
The Vietnam Report JSC announced the list of top 10 reputable companies in the pharmacy, medical supply and health care for 2024.
President-elect Donald Trump’s choice to run the sprawling government agency that administers Medicare, Medicaid, and the Affordable Care Act marketplace — celebrity doctor Mehmet Oz — recently held broad investments in health care, tech, and food companies that would pose significant conflicts of interest.